CLL Coverage from Every Angle

Jennifer R. Brown, MD, PhD, on Treating CLL/SLL With Ibrutinib: Findings From the RESONATE Trial

Posted: Tuesday, September 10, 2019

Jennifer R. Brown, MD, PhD, of Dana-Farber Cancer Institute, discusses the long-term final findings on the use of ibrutinib and how she expects it will be positioned in the treatment landscape for chronic lymphocytic leukemia or small lymphocytic lymphoma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.